GENOCEA BIOSCIENCES INC - COM NEW (GNCA)

CUSIP: 372427401

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM NEW
Total 13F shares
13,870,003
Share change
+6,935,149
Total reported value
$23,858,000
Put/Call ratio
0.89%
Price per share
$1.72
Number of holders
30
Value change
+$11,885,539
Number of buys
12
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 372427401?
CUSIP 372427401 identifies GNCA - GENOCEA BIOSCIENCES INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENOCEA BIOSCIENCES INC - COM NEW (GNCA) as of Q1 2020

As of 31 Mar 2020, GENOCEA BIOSCIENCES INC - COM NEW (GNCA) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,870,003 shares. The largest 10 holders included NEA Management Company, LLC, BVF INC/IL, VANGUARD GROUP INC, KINGDON CAPITAL MANAGEMENT, L.L.C., DAFNA Capital Management LLC, SABBY MANAGEMENT, LLC, FNY Investment Advisers, LLC, Endurant Capital Management LP, Alyeska Investment Group, L.P., and Polaris Venture Management Co. V, L.L.C.. This page lists 30 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.